Relief Therapeutics将获得研究药物RLF-TD 011的欧洲专利
Hawkinsight
2025-02-11 18:03:06
2.25W
尼古拉斯_
- Relief Therapeutics (OTCQB：RLFTY) Tuesday said that the European Patent Office has issued a Decision to Grant for its patent application titled \"Therapeutic Uses of Oxidizing Hypotonic Acid Solutions.\"
- This patent will protect therapeutic applications of Relief's (OTCQB：RLFTY) proprietary, highly pure
免责声明：本文观点来自原作者，不代表Hawk Insight的观点和立场。文章内容仅供参考、交流、学习，不构成投资建议。如涉及版权问题，请联系我们删除。
